| Millard County Care And Rehabilitation | |
| 150 South White Sage Avenue, Delta, Utah 84624 | |
| (435) 864-2944 | |
| Name | Millard County Care And Rehabilitation |
|---|---|
| Location | 150 South White Sage Avenue, Delta, Utah |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 60 |
| Occupancy Rate | 77% |
| Medicare ID (CCN) | 465157 |
| Legal Business Name | Millard County Care & Rehabilitation Inc |
| Ownership Type | Government - County |
| NPI Number | 1851579072 |
| Organization Name | MILLARD COUNTY CARE & REHABILITATION INC |
| Address | 150 White Sage Ave, Delta, UT 84624 |
| Phone Number | 435-864-2944 |
News Archive
RegeneRx Biopharmaceuticals, Inc. reports that U.S. researchers have found that Thymosin Beta 4 (Tβ4) promotes statistically significant recovery of peripheral neuropathy in type II diabetic mice including recovery of neurovascular dysfunction in the sciatic nerve and recovery of neurological function.
Using a homemade, high-tech microscope, scientists at the University of Virginia School of Medicine have revealed how a cancer-causing virus anchors itself to our DNA. That discovery could pave the way for doctors to cure incurable diseases by flushing out viruses, including HPV and Epstein-Barr, that now permanently embed themselves in our cells.
Young children in developing countries are infected at an early age with the bacterium Helicobacter pylori, which can cause peptic ulcers and stomach cancer. New findings show that childrens´ immune responses help in fighting the bacteria. In addition, breastfeeding and better hygiene appear to protect against infection. The results provide hope for a vaccine, according to research from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor (CAR) T cell therapy Kymriah (tisagenlecleucel, formerly CTL019) led to long-lasting remissions in patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL).
Biosense Webster EMEA, a Division of Johnson & Johnson Medical NV/SA and leader in the treatment of Atrial Fibrillation, is launching its ‘Power to Heal' campaign across Europe, the Middle East and Africa at the European Heart Rhythm Association Congress 2018.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
RegeneRx Biopharmaceuticals, Inc. reports that U.S. researchers have found that Thymosin Beta 4 (Tβ4) promotes statistically significant recovery of peripheral neuropathy in type II diabetic mice including recovery of neurovascular dysfunction in the sciatic nerve and recovery of neurological function.
Using a homemade, high-tech microscope, scientists at the University of Virginia School of Medicine have revealed how a cancer-causing virus anchors itself to our DNA. That discovery could pave the way for doctors to cure incurable diseases by flushing out viruses, including HPV and Epstein-Barr, that now permanently embed themselves in our cells.
Young children in developing countries are infected at an early age with the bacterium Helicobacter pylori, which can cause peptic ulcers and stomach cancer. New findings show that childrens´ immune responses help in fighting the bacteria. In addition, breastfeeding and better hygiene appear to protect against infection. The results provide hope for a vaccine, according to research from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor (CAR) T cell therapy Kymriah (tisagenlecleucel, formerly CTL019) led to long-lasting remissions in patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL).
Biosense Webster EMEA, a Division of Johnson & Johnson Medical NV/SA and leader in the treatment of Atrial Fibrillation, is launching its ‘Power to Heal' campaign across Europe, the Middle East and Africa at the European Heart Rhythm Association Congress 2018.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $14805 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 8.42 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 26.32 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 67.65 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 5.68 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.57 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 18.38 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.67 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.42 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 25.27 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 86.67 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 3.85 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 11.05 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 40.53 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 7.03 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.49 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 57.35 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 96.47 | 82.93 |
News Archive
RegeneRx Biopharmaceuticals, Inc. reports that U.S. researchers have found that Thymosin Beta 4 (Tβ4) promotes statistically significant recovery of peripheral neuropathy in type II diabetic mice including recovery of neurovascular dysfunction in the sciatic nerve and recovery of neurological function.
Using a homemade, high-tech microscope, scientists at the University of Virginia School of Medicine have revealed how a cancer-causing virus anchors itself to our DNA. That discovery could pave the way for doctors to cure incurable diseases by flushing out viruses, including HPV and Epstein-Barr, that now permanently embed themselves in our cells.
Young children in developing countries are infected at an early age with the bacterium Helicobacter pylori, which can cause peptic ulcers and stomach cancer. New findings show that childrens´ immune responses help in fighting the bacteria. In addition, breastfeeding and better hygiene appear to protect against infection. The results provide hope for a vaccine, according to research from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor (CAR) T cell therapy Kymriah (tisagenlecleucel, formerly CTL019) led to long-lasting remissions in patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL).
Biosense Webster EMEA, a Division of Johnson & Johnson Medical NV/SA and leader in the treatment of Atrial Fibrillation, is launching its ‘Power to Heal' campaign across Europe, the Middle East and Africa at the European Heart Rhythm Association Congress 2018.
› Verified 1 days ago
Millard County Care And Rehabilitation Location: 150 South White Sage Avenue, Delta, Utah 84624 Phone: (435) 864-2944 |